Pharmacokinetic and Glucodynamic Responses of Ultra Rapid Lispro vs Lispro Across a Clinically Relevant Range of Subcutaneous Doses in Healthy Subjects-Reference-Cited by-同舟云学术

Pharmacokinetic and Glucodynamic Responses of Ultra Rapid Lispro vs Lispro Across a Clinically Relevant Range of Subcutaneous Doses in Healthy Subjects

Published:2020-09 Issue:9 Volume:42 Page:1762-1777.e4
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Leohr Jennifer^ORCID,Dellva Mary Anne,LaBell Elizabeth,Coutant David E.,Klein Oliver,Plum-Moerschel Leona^ORCID,Zijlstra Eric,Linnebjerg Helle^ORCID

Funder

Eli Lilly and Company

Novo Nordisk

Aerami Therapeutics

Roche Diabetes Care

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Standards of medical care in diabetes—2009;Diabetes Care,2009

2. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations;Ceriello;Diabet Med,2008

3. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes;Nathan;N Engl J Med,2005

4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;N Engl J Med,1993

5. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges;Davies;Int J Obes Relat Metab Disord,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refining Insulin on Board with netIOB for Automated Insulin Delivery;Journal of Diabetes Science and Technology;2024-08-14

2. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

3. Insulin;Pharmaceutical Biotechnology;2024

4. Ultra‐rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double‐blind phase 3 study;Diabetes, Obesity and Metabolism;2023-10-23

5. Ultra rapid lispro (Lyumjev®) shortens time to recovery from hyperglycaemia compared to Humalog® in individuals with type 1 diabetes on continuous subcutaneous insulin infusion;Diabetes, Obesity and Metabolism;2023-10-09